Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Predictors of Religious Orientation Attitudes in Menopausal Women (MENO-RO)

26 de agosto de 2026 actualizado por: Aslıhan Turan, KTO Karatay University

Predictors of Attitudes Toward Religious Orientation in Menopausal Women: A Cross-Sectional Study

This descriptive, cross-sectional study examines whether the severity of menopausal symptoms and attitudes toward sexual myths predict intrinsic religious orientation in menopausal women. Menopause is a multidimensional transition with biological, psychological, social and spiritual aspects, and in societies with a strong cultural and religious fabric women may draw on religious orientation as a coping and meaning-making resource. Participants are healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease, recruited in Konya, Turkey. Data are collected face to face using a personal information form, the Menopause Rating Scale, the Intrinsic Religious Orientation Scale and the Sexual Myths Scale, and analysed with multiple regression.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Descripción detallada

Background:

Menopause is a multidimensional transition in a woman's life with biological, psychological, social and spiritual dimensions. With increasing life expectancy, women spend roughly a third of their lives in the menopausal period. The decline in oestrogen is associated with hot flushes, sleep disturbance, mood fluctuations and sexual dysfunction, which can adversely affect quality of life. The literature emphasises that the menopause experience is shaped not only biologically but also by sociocultural factors and religious beliefs, and that religious and spiritual orientation can increase psychological resilience and reduce anxiety and stress. Sexual dysfunction is highly prevalent in this period, and sexuality is closely linked to lifestyle, cultural roles, religious beliefs and societal myths; low sexual awareness and adoption of sexual myths may intensify the perceived severity of menopausal symptoms.

Aim:

To determine the predictive effect of the physical and psychological symptoms of menopause and of attitudes toward sexual myths on the intrinsic religious orientation of menopausal women.

Design and setting:

Descriptive, cross-sectional design. The study population comprises healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey. The sample consists of women who meet the inclusion criteria and volunteer to participate.

Sample size:

Calculated with G*Power 3. For a linear multiple regression model with a medium effect size of 0.15, power of 0.95 and a Type I error of 0.05, a minimum of 89 participants is required. Allowing for a possible 10 percent data loss, 97 participants are planned.

Measures:

A personal information form (15 items covering sociodemographic and obstetric characteristics), the Menopause Rating Scale (MRS), the Intrinsic Religious Orientation Scale and the Sexual Myths Scale. Written informed consent is obtained; author permissions for the scales are obtained by email. Data are collected face to face.

Statistical analysis:

Analyses are performed with IBM SPSS Statistics v29.0. Normality is assessed with visual and analytical methods (Kolmogorov-Smirnov test). Descriptive statistics are reported as mean and standard deviation or median (minimum to maximum) as appropriate. Multiple regression models are built to estimate regression coefficients and 95 percent confidence intervals for the relationships between religious orientation and age, number of pregnancies, menopause duration, menopause symptom severity and sexual myths. Group comparisons use the Mann-Whitney U and Kruskal-Wallis tests where appropriate. Significance is set at p less than 0.05.

Ethics:

Institutional permission and ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University before the study begins. Written informed consent is obtained from all participants.

Tipo de estudio

De observación

Inscripción (Estimado)

97

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Konya, Turquía (Türkiye)
        • Reclutamiento
        • Recruitment site (to be specified), Konya
        • Contacto:
          • Aslihan Turan
        • Investigador principal:
          • Aslihan Turan

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey, who volunteer and provide written informed consent.

Descripción

Inclusion Criteria:

  • Woman aged 49 to 59 years
  • Diagnosis of menopause
  • No chronic health problem
  • Volunteers to participate and provides written informed consent

Exclusion Criteria:

* Presence of a chronic disease (e.g. cardiac disease, diabetes, hypertension)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Menopausal women aged 49 to 59
Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease (such as cardiac disease, diabetes or hypertension), recruited in Konya, Turkey, who volunteer to participate. Participants complete a single battery of self-report scales collected face to face; no intervention is applied.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Intrinsic religious orientation (Intrinsic Religious Orientation Scale)
Periodo de tiempo: Single assessment at enrollment (Day 1)
The Intrinsic Religious Orientation Scale (Hoge, 1972; Turkish standardisation by Karaca, 2001) contains 10 items measuring intrinsic religious motivation. Seven items are positively worded and three are negatively worded and reverse coded. Items are rated on a 5-point Likert format scored from 0 (weakest) to 4 (strongest), giving a total score of 0 to 40, with higher scores indicating stronger intrinsic religious orientation.
Single assessment at enrollment (Day 1)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Menopausal symptom severity (Menopause Rating Scale, MRS)
Periodo de tiempo: Single assessment at enrollment (Day 1)
The Menopause Rating Scale (Schneider et al., 2000; Turkish adaptation by Can Gurkan, 2005) is an 11-item scale with three subscales: somatic complaints, psychological complaints and urogenital complaints. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe), giving a total score of 0 to 44, with higher scores indicating greater symptom severity.
Single assessment at enrollment (Day 1)
Sexual myths (Sexual Myths Scale, SMS)
Periodo de tiempo: Single assessment at enrollment (Day 1)
The Sexual Myths Scale (Golbasi et al., 2016) is a 28-item, 5-point Likert scale with eight subscales (sexual orientation, gender, age and sexuality, sexual behaviour, masturbation, sexual violence, sexual intercourse and sexual satisfaction). The total score ranges from 28 to 140, with higher scores indicating a greater likelihood of holding sexual myths.
Single assessment at enrollment (Day 1)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Aslihan Turan, KTO Karatay University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

26 de agosto de 2026

Finalización primaria (Estimado)

1 de febrero de 2027

Finalización del estudio (Estimado)

2 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

26 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

26 de agosto de 2026

Publicado por primera vez (Actual)

1 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

26 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • MENO-RELIG-2026

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .